RadNet Inc. (NASDAQ:RDNT) reported ($0.03) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.06) by $0.03. The company had revenue of $168.90 million for the quarter, compared to the consensus estimate of $173.53 million. Analysts expect that Radnet will post $0.19 EPS for the current fiscal year. RadNet Inc. (NASDAQ:RDNT) net profit margin is 0.30% and weekly performance is 17.61%. On last trading day company shares ended up $7.48. Analysts mean target price for the company is $7.50. RadNet Inc. (NASDAQ:RDNT) distance from 50-day simple moving average (SMA50) is 48.72%.
On 6 JUNE Select Medical Holdings Corporation (NYSE:SEM) reported $0.25 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.24 by $0.01. The company had revenue of $762.60 million for the quarter, compared to the consensus estimate of $760.50 million. During the same quarter last year, the company posted $0.25 earnings per share. Select Medical Holdings’s revenue was up 1.7% compared to the same quarter last year. On average, analysts predict that Select Medical Holdings will post $0.94 earnings per share for the current fiscal year. Select Medical Holdings Corporation (NYSE:SEM) shares advanced 1.84% in last trading session and ended the day on $15.47. SEM Gross Margin is 16.00% and its return on assets is 5.10%. Select Medical Holdings Corporation (NYSE:SEM) quarterly performance is 32.22%.
On 6 JUNE Amsurg Corp (NASDAQ:AMSG) reported $0.53 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.55 by $0.02. The company had revenue of $263.11 million for the quarter, compared to the consensus estimate of $272.09 million. During the same quarter in the prior year, the company posted $0.52 earnings per share. The company’s quarterly revenue was up 1.9% on a year-over-year basis. Amsurg Corp (NASDAQ:AMSG) shares moved up 3.23% in last trading session and was closed at $50.51, while trading in range of $49.07 – $50.61. Amsurg Corp (NASDAQ:AMSG) year to date (YTD) performance is 10.00%.
On 6 JUNE Enzo Biochem, Inc. (NYSE:ENZ) announced that it has been assigned U.S. Patent Office Patent No. 8,742,090, related to the construct of an artificial vector capable of greater efficiency, in general, in targeting specific cells in the application of gene therapy and gene transfer technology. Enzo Biochem, Inc. (NYSE:ENZ) ended the last trading day at $4.62. Company weekly volatility is calculated as 5.86% and price to cash ratio as 26.58. Enzo Biochem, Inc. (NYSE:ENZ) showed a positive weekly performance of 12.41%.
On 3 JUNE Alder Biopharmaceuticals Inc (NASDAQ:ALDR) issued an outperform rating and a price objective on the stock. Alder Biopharmaceuticals Inc (NASDAQ:ALDR) weekly performance is 46.37%. On last trading day company shares ended up $15.72. Analysts mean target price for the company is $23.00. Alder Biopharmaceuticals Inc (NASDAQ:ALDR) distance from 50-day simple moving average (SMA50) is 44.90%.